FIELD: medicine. SUBSTANCE: proposed composition contains (mass %): dimethyl methyl vinylpolysiloxane 100, oligohydride siloxane 1-3, oligodimethyl siloxane 100-140, carbonyl iron 20-40 and catalytic amount of chloroplatinic acid. EFFECT: reliable occlusion.
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR EMBOLIZATION AND HYPERTHERMIA OF VASCULAR TUMORS | 2017 |
|
RU2670446C1 |
| METHOD OF TREATMENT OF PARENCHYMATOUS ORGAN TUMORS | 1995 |
|
RU2065734C1 |
| RADIOENDOVASCULAR RENAL ARTERY OCCLUSION METHOD FOR CARRYING OUT NEPHRECTOMY | 2003 |
|
RU2265408C2 |
| METHOD FOR SPINAL ARTERY EMBOLISATION IN VERTEBRAL TUMOURS | 2023 |
|
RU2834530C1 |
| MEANS FOR STOPPING HEMORRHAGE | 0 |
|
SU1097318A1 |
| THERMO-CONTROLLED COMPOSITION TO STOP BLEEDING TEMPORARY | 2023 |
|
RU2810584C1 |
| METHOD OF EMBOLISATION OF CEREBRAL ARTERIOVENOUS MALFORMATIONS | 2012 |
|
RU2497457C1 |
| METHOD OF TREATMENT OF CONGENITAL ARTERY/VENOUS DYSPLASIA | 0 |
|
SU1333315A1 |
| POLYMERIC MATERIAL OF MEDICAL PURPOSE FOR EMBOLIZATION | 2017 |
|
RU2669801C1 |
| EMBOLIZATION METHOD FOR TREATING PATHOLOGIC BY-PASS PROCESSES IN BRAIN, DURA MATER, PIA MATER, ARACHNOIDEA ENCEPHALI AND HEAD INTEGUMENTS | 1993 |
|
RU2104055C1 |
Authors
Dates
1997-02-20—Published
1995-05-16—Filed